Biofrontera Inc.(BFRI)

Medical - Pharmaceuticals · Woburn, MA

$0.89-0.00 (-0.04%)

Delayed quote: Oct 6, 2026, 12:24 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T16:25:54.181Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:25:54.181Z.

Quote observation: 2026-10-06T16:24:53.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 11,401,378
Total debt · period ending 2026-06-30: 7,504,000
Cash · period ending 2026-06-30: 4,659,000
TTM free cash flow · period ending 2026-06-30: -7,934,000

FMP input reference: b47096c20191003074eea3dc75a1498d2bed5743fa2797f84e024bc92f81a74c

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BFRI EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

BFRI Competitors' EV/FCF Ratio

BFRI

Biofrontera Inc.

Current

Market Cap

$11.40M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PHIO

Phio Pharmaceuticals Corp.

vs BFRI

Market Cap

$11.45M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLUR

Pluri Inc.

vs BFRI

Market Cap

$11.54M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KPRX

Kiora Pharmaceuticals, Inc.

vs BFRI

Market Cap

$11.30M

EV/FCF Ratio

N/A

TTM Avg

5.23x

3Y Avg

5.23x

5Y Avg

5.23x

ADIL

Adial Pharmaceuticals, Inc.

vs BFRI

Market Cap

$11.37M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BFRG

Bullfrog AI Holdings, Inc. Common Stock

vs BFRI

Market Cap

$12.37M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIVI

BioVie Inc.

vs BFRI

Market Cap

$11.11M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GDTC

CytoMed Therapeutics Limited

vs BFRI

Market Cap

$10.52M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNSY

Cerenome, Inc.

vs BFRI

Market Cap

$11.02M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CABR

Caring Brands, Inc.

vs BFRI

Market Cap

$10.68M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Biofrontera Inc. (BFRI)	$11.40M	N/A	N/A	N/A	N/A
Phio Pharmaceuticals Corp. (PHIO)vs ›	$11.45M	N/A	N/A	N/A	N/A
Pluri Inc. (PLUR)vs ›	$11.54M	N/A	N/A	N/A	N/A
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.30M	N/A	5.23x	5.23x	5.23x
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$11.37M	N/A	N/A	N/A	N/A
Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›	$12.37M	N/A	N/A	N/A	N/A
BioVie Inc. (BIVI)vs ›	$11.11M	N/A	N/A	N/A	N/A
CytoMed Therapeutics Limited (GDTC)vs ›	$10.52M	N/A	N/A	N/A	N/A
Cerenome, Inc. (CNSY)vs ›	$11.02M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$10.68M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

BFRI EV/FCF Ratio Metrics

BFRI Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics